Nanomedicine-based cancer immunotherapy: recent trends and future perspectives
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Nanomedicine-based cancer immunotherapy: recent trends and future perspectives
Authors
Keywords
-
Journal
CANCER GENE THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-02-09
DOI
10.1038/s41417-021-00299-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nonlinear response to cancer nanotherapy due to macrophage interactions revealed by mathematical modeling and evaluated in a murine model via CRISPR-modulated macrophage polarization
- (2020) Fransisca Leonard et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Self-Assembled Nanoparticles Prepared from Low-Molecular-Weight PEI and Low-Generation PAMAM for EGFRvIII-Chimeric Antigen Receptor Gene Loading and T-Cell Transient Modification
- (2020) Qianru Yu et al. International Journal of Nanomedicine
- Tertiary lymphoid structures improve immunotherapy and survival in melanoma
- (2020) Rita Cabrita et al. NATURE
- Engineered probiotics for local tumor delivery of checkpoint blockade nanobodies
- (2020) Candice R. Gurbatri et al. Science Translational Medicine
- Nanotechnology Promotes Genetic and Functional Modifications of Therapeutic T Cells Against Cancer
- (2020) Ahmed M. E. Abdalla et al. Advanced Science
- Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer
- (2020) Kuan-Wei Huang et al. Science Advances
- Reshaping Tumor Immune Microenvironment through Acidity-Responsive Nanoparticles Featured with CRISPR/Cas9-Mediated Programmed Death-Ligand 1 Attenuation and Chemotherapeutics-Induced Immunogenic Cell Death
- (2020) Kun Tu et al. ACS Applied Materials & Interfaces
- Nanoparticle interactions with immune cells dominate tumor retention and induce T cell–mediated tumor suppression in models of breast cancer
- (2020) Preethi Korangath et al. Science Advances
- Nanotechnology and immunoengineering: How nanotechnology can boost CAR-T therapy
- (2020) Waqas Nawaz et al. Acta Biomaterialia
- Dendritic cell vaccine for the effective immunotherapy of breast cancer
- (2020) Jiang Ni et al. BIOMEDICINE & PHARMACOTHERAPY
- Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy
- (2020) Pengfei Zhao et al. BIOMATERIALS
- Surface-engineered multimodal magnetic nanoparticles to manage CNS diseases
- (2019) Asahi Tomitaka et al. DRUG DISCOVERY TODAY
- Delivery technologies for cancer immunotherapy
- (2019) Rachel S. Riley et al. NATURE REVIEWS DRUG DISCOVERY
- Emerging Nano-/Microapproaches for Cancer Immunotherapy
- (2019) Yu Mi et al. Advanced Science
- Enhancing PD-1 Gene Silence in T Lymphocytes by Comparing the Delivery Performance of Two Inorganic Nanoparticle Platforms
- (2019) Yanheng Wu et al. Nanomaterials
- Human Cancer Cell Membrane-Coated Biomimetic Nanoparticles Reduce Fibroblast-Mediated Invasion and Metastasis and Induce T-Cells
- (2019) Jiefu Jin et al. ACS Applied Materials & Interfaces
- Nanoenabled Modulation of Acidic Tumor Microenvironment Reverses Anergy of Infiltrating T Cells and Potentiates Anti-PD-1 Therapy
- (2019) Yu-Xue Zhang et al. NANO LETTERS
- Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors
- (2019) Xiaopin Duan et al. Nature Communications
- Engineering nanoparticles to locally activate T cells in the tumor microenvironment
- (2019) Dangge Wang et al. Science Immunology
- A Designer Scaffold with Immune Nanoconverters for Reverting Immunosuppression and Enhancing Immune Checkpoint Blockade Therapy
- (2019) Hathaichanok Phuengkham et al. ADVANCED MATERIALS
- Activating Antitumor Immunity and Antimetastatic Effect Through Polydopamine‐Encapsulated Core–Shell Upconversion Nanoparticles
- (2019) Shuangqian Yan et al. ADVANCED MATERIALS
- Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis
- (2019) Wenqi Yu et al. BIOMATERIALS
- Blood–brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy
- (2019) Anna Galstyan et al. Nature Communications
- Co-localized delivery of nanomedicine and nanovaccine augments the postoperative cancer immunotherapy by amplifying T-cell responses
- (2019) Xiang Liu et al. BIOMATERIALS
- Multiboosting of Cancer Immunotherapy by a Core–Shell Delivery System
- (2019) Fuping Shao et al. MOLECULAR PHARMACEUTICS
- Engineering strategies to overcome the current roadblocks in CAR T cell therapy
- (2019) Sarwish Rafiq et al. Nature Reviews Clinical Oncology
- Macrophage-Specific in Vivo Gene Editing Using Cationic Lipid-Assisted Polymeric Nanoparticles
- (2018) Ying-Li Luo et al. ACS Nano
- Size/Charge Changeable Acidity-Responsive Micelleplex for Photodynamic-Improved PD-L1 Immunotherapy with Enhanced Tumor Penetration
- (2018) Liangliang Dai et al. ADVANCED FUNCTIONAL MATERIALS
- A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy
- (2018) Yu Mi et al. ADVANCED MATERIALS
- CRISPRed Macrophages for Cell-Based Cancer Immunotherapy
- (2018) Moumita Ray et al. BIOCONJUGATE CHEMISTRY
- Nanoscale Metal–Organic Framework Overcomes Hypoxia for Photodynamic Therapy Primed Cancer Immunotherapy
- (2018) Guangxu Lan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy
- (2018) David R. Wilson et al. Nanomedicine-Nanotechnology Biology and Medicine
- Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery
- (2018) Li Tang et al. NATURE BIOTECHNOLOGY
- In situ formed reactive oxygen species–responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy
- (2018) Chao Wang et al. Science Translational Medicine
- CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction
- (2018) Natnaree Siriwon et al. Cancer Immunology Research
- Elimination of established tumors with nanodisc-based combination chemoimmunotherapy
- (2018) Rui Kuai et al. Science Advances
- Low-dose X-ray radiotherapy–radiodynamic therapy via nanoscale metal–organic frameworks enhances checkpoint blockade immunotherapy
- (2018) Kuangda Lu et al. Nature Biomedical Engineering
- A phase I trial of PD-1 deficient engineered T cells with CRISPR/Cas9 in patients with advanced non-small cell lung cancer.
- (2018) You Lu et al. JOURNAL OF CLINICAL ONCOLOGY
- Targeted delivery of a PD-1-blocking scFv by CAR-T cells enhances anti-tumor efficacy in vivo
- (2018) Sarwish Rafiq et al. NATURE BIOTECHNOLOGY
- Metallo-Curcumin-Conjugated DNA Complexes Induces Preferential Prostate Cancer Cells Cytotoxicity and Pause Growth of Bacterial Cells
- (2018) Srivithya Vellampatti et al. Scientific Reports
- Bacterial Resistance and Prostate Cancer Susceptibility Toward Metal-Ion-doped DNA Complexes
- (2018) Srivithya Vellampatti et al. ACS Applied Materials & Interfaces
- Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
- (2018) Wei-Jie Cheng et al. International Journal of Nanomedicine
- The application of nanotechnology in immune checkpoint blockade for cancer treatment
- (2018) Huan Deng et al. JOURNAL OF CONTROLLED RELEASE
- Cancer immunoediting and resistance to T cell-based immunotherapy
- (2018) Jake S. O’Donnell et al. Nature Reviews Clinical Oncology
- CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice
- (2017) Farhad Jadidi-Niaragh et al. JOURNAL OF CONTROLLED RELEASE
- Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
- (2017) Chang Liu et al. JOURNAL OF CONTROLLED RELEASE
- Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy
- (2017) Yuchen Fan et al. NANO LETTERS
- Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
- (2017) Justin Eyquem et al. NATURE
- In vivo CRISPR screening identifies Ptpn2 as a cancer immunotherapy target
- (2017) Robert T. Manguso et al. NATURE
- Antigen-capturing nanoparticles improve the abscopal effect and cancer immunotherapy
- (2017) Yuanzeng Min et al. Nature Nanotechnology
- Delivery technologies for genome editing
- (2017) Hao Yin et al. NATURE REVIEWS DRUG DISCOVERY
- Synergistic Immuno Photothermal Nanotherapy (SYMPHONY) for the Treatment of Unresectable and Metastatic Cancers
- (2017) Yang Liu et al. Scientific Reports
- Multiplex Genome Editing to Generate Universal CAR T Cells Resistant to PD1 Inhibition
- (2016) Jiangtao Ren et al. CLINICAL CANCER RESEARCH
- Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation
- (2016) Shi-Yong Li et al. JOURNAL OF CONTROLLED RELEASE
- Photodynamic Therapy Mediated by Nontoxic Core–Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer
- (2016) Xiaopin Duan et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Core-shell nanoscale coordination polymers combine chemotherapy and photodynamic therapy to potentiate checkpoint blockade cancer immunotherapy
- (2016) Chunbai He et al. Nature Communications
- CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
- (2016) Shu Su et al. Scientific Reports
- Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells
- (2015) João Conde et al. ADVANCED FUNCTIONAL MATERIALS
- In vivo genome editing using Staphylococcus aureus Cas9
- (2015) F. Ann Ran et al. NATURE
- Therapeutic genome editing: prospects and challenges
- (2015) David Benjamin Turitz Cox et al. NATURE MEDICINE
- Modeling colorectal cancer using CRISPR-Cas9–mediated engineering of human intestinal organoids
- (2015) Mami Matano et al. NATURE MEDICINE
- Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
- (2015) Kathrin Schumann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neoantigens in cancer immunotherapy
- (2015) T. N. Schumacher et al. SCIENCE
- Polymer nanoparticles for enhanced immune response: Combined delivery of tumor antigen and small interference RNA for immunosuppressive gene to dendritic cells
- (2014) Min Beom Heo et al. Acta Biomaterialia
- In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9
- (2014) Lukasz Swiech et al. NATURE BIOTECHNOLOGY
- STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo
- (2014) Aws Alshamsan et al. Translational Oncology
- Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells
- (2013) Min Beom Heo et al. BIOMATERIALS
- Inducers of immunogenic cancer cell death
- (2013) Aleksandra M. Dudek et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Intravenous Delivery of siRNA Targeting CD47 Effectively Inhibits Melanoma Tumor Growth and Lung Metastasis
- (2013) Yuhua Wang et al. MOLECULAR THERAPY
- A20 Silencing by Lipid Envelope-Type Nanoparticles Enhances the Efficiency of Lipopolysaccharide-Activated Dendritic Cells
- (2011) Shota Warashina et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Therapeutic siRNA silencing in inflammatory monocytes in mice
- (2011) Florian Leuschner et al. NATURE BIOTECHNOLOGY
- A multifunctional core–shell nanoparticle for dendritic cell-based cancer immunotherapy
- (2011) Nam-Hyuk Cho et al. Nature Nanotechnology
- Nanoparticles for ex vivo siRNA delivery to dendritic cells for cancer vaccines: Programmed endosomal escape and dissociation☆
- (2010) Hidetaka Akita et al. JOURNAL OF CONTROLLED RELEASE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started